Friday - December 19, 2025

Dr. Cameron Rokhsar Presents First Large Case Series on Non-Surgical Treatment of Lipomas Using Kybella® (Deoxycholic Acid) Injections

New York, NY – December 16, 2025 – In a landmark advancement in minimally invasive dermatologic surgery, Dr. Cameron Rokhsar, double board-certified dermatologist and dermatologic surgeon, will present the first large case series demonstrating the non-surgical treatment of lipomas using … Continue reading

Austin’s Evolving CBD Market: Minor Cannabinoids, Raw Extraction & Science-Driven Formulations

True Hemp Science named Austin’s Best CBD. A shift toward science-backed products has created new opportunities for research-focused companies emphasizing traceability, low-temperature extraction, and careful sourcing. One such business, True Hemp Science, was recently named among Austin Fit Magazine’s Best … Continue reading

Ecosense Unveils EcoQube Flex™: The First Battery-Powered, Truly Portable Continuous Radon Monitor Set to Disrupt Home Health Technology in 2026

Next-generation ion chamber platform delivers lab-level accuracy, instant radon insights, and true mobility for every homeowner San Jose, California – December 15, 2025 – Ecosense, a worldwide leader in cutting-edge radon detection technology, today announced the launch of EcoQube Flex™, … Continue reading

Rett Syndrome Clinical Trial Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Rett Syndrome Pipeline Insight 2025” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Rett Syndrome pipeline landscape. It covers the Rett Syndrome pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading

Exosomes Clinical Trial Pipeline Gains Momentum: 80+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Exosomes Pipeline Insight 2025” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in the Exosomes pipeline landscape. It covers the Exosomes Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Exosomes Pipeline … Continue reading

Creative Diagnostics Introduces Advanced Hepatitis Virus Animal Models to Accelerate HBV Drug and Vaccine Development

Creative Diagnostics launches Hepatitis Virus Animal Model services for research applications. As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics has announced the launch of its Hepatitis Virus Animal Model services, to provide researchers and … Continue reading

STEMart Enhances Medical Device Safety Testing with New In Vitro Micronucleus Test Service

STEMart introduces In Vitro Micronucleus Test service to meet the genotoxicity testing requirements for medical devices. STEMart, a US-based provider of comprehensive services for all phases of medical device development, has announced the availability of its robust In Vitro Micronucleus … Continue reading